Invivyd (IVVD) had the highest return between December 13, 2023 and December 20, 2023 by a small-cap US stock, returning 110.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Invivyd (IVVD) | 12/13/2023 - 12/20/2023 | 110.19% |
Canaan (CAN) | 12/13/2023 - 12/20/2023 | 108.94% |
Loandepot (LDI) | 12/13/2023 - 12/20/2023 | 65% |
Highest Performances (MAAS) | 12/13/2023 - 12/20/2023 | 58.35% |
DeFi Technologies (DEFT) | 12/13/2023 - 12/20/2023 | 56.61% |
Esperion Therapeutics (ESPR) | 12/13/2023 - 12/20/2023 | 53.38% |
Immix Biopharma (IMMX) | 12/13/2023 - 12/20/2023 | 46.19% |
Wheels Up Experience (UP) | 12/13/2023 - 12/20/2023 | 45.45% |
Gyre Therapeutics (GYRE) | 12/13/2023 - 12/20/2023 | 44.22% |
TriSalus Life Sciences (TLSI) | 12/13/2023 - 12/20/2023 | 43.68% |
Meihua International Medical Technologies (MHUA) | 12/13/2023 - 12/20/2023 | 39.8% |
Argo Blockchain PLC ADR (ARBK) | 12/13/2023 - 12/20/2023 | 36.94% |
Hyliion (HYLN) | 12/13/2023 - 12/20/2023 | 34.48% |
Intrepid Potash (IPI) | 12/13/2023 - 12/20/2023 | 34.48% |
Altimmune (ALT) | 12/13/2023 - 12/20/2023 | 34.12% |
SolarEdge Technologies (SEDG) | 12/13/2023 - 12/20/2023 | 32.64% |
Better Home & Finance (BETR) | 12/13/2023 - 12/20/2023 | 32.55% |
Blue Ridge Bankshares (BRBS) | 12/13/2023 - 12/20/2023 | 31.8% |
4D Molecular Therapeutics (FDMT) | 12/13/2023 - 12/20/2023 | 31.65% |
Monopar Therapeutics (MNPR) | 12/13/2023 - 12/20/2023 | 31.61% |
American Battery Technology Company Common Stock (ABAT) | 12/13/2023 - 12/20/2023 | 31.11% |
Absci (ABSI) | 12/13/2023 - 12/20/2023 | 30.77% |
Worthington Steel (WS) | 12/13/2023 - 12/20/2023 | 28.9% |
Community Health Systems (CYH) | 12/13/2023 - 12/20/2023 | 28.87% |
Byrna Technologies (BYRN) | 12/13/2023 - 12/20/2023 | 28.74% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
